Correlation Between Akero Therapeutics and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Black Diamond Therapeutics, you can compare the effects of market volatilities on Akero Therapeutics and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Black Diamond.
Diversification Opportunities for Akero Therapeutics and Black Diamond
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akero and Black is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Black Diamond go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Black Diamond
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.89 times more return on investment than Black Diamond. However, Akero Therapeutics is 1.13 times less risky than Black Diamond. It trades about 0.1 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 2,971 in Akero Therapeutics on August 28, 2024 and sell it today you would earn a total of 206.00 from holding Akero Therapeutics or generate 6.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Akero Therapeutics |
| Black Diamond Therap |
Akero Therapeutics and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Black Diamond
The main advantage of trading using opposite Akero Therapeutics and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. HCW Biologics | Akero Therapeutics vs. Scpharmaceuticals | Akero Therapeutics vs. Milestone Pharmaceuticals |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |